Versuchen GOLD - Frei

Impact of Digital Transformation on Lab Efficiency

Bio Spectrum

|

BioSpectrum India Nov 2024

The rapid advancement of technology has triggered a wave of digital transformation across various industries, and laboratories are no exception. Laboratories, especially those involved in research, clinical diagnostics, and development, have seen significant shifts in the way they operate due to the integration of advanced digital tools. From optimising workflows to improving accuracy, digital transformation is revolutionising lab operations, making them faster, more efficient, and capable of handling larger data volumes. This shift is not just a technological upgrade but a complete rethinking of how laboratories function to deliver more value while meeting increasingly stringent compliance and operational standards. Let's find out more.

- Surjeet Thakur

Impact of Digital Transformation on Lab Efficiency

Digital transformation in laboratories is fundamentally reshaping workflows. Historically, lab operations have depended heavily on manual processes—data entry, analysis, and report generation—which were time-intensive and prone to errors. However, the introduction of Laboratory Information Management Systems (LIMS) has been a game-changer. LIMS enables laboratories to standardise their workflows, ensuring consistency and minimising human error. With automation at the core, tasks that once required several hours or even days can now be completed in minutes, allowing lab technicians to focus on higher-value activities.

This reconfiguration of workflows is critical for labs handling large volumes of data. Automation allows them to manage the influx without compromising on quality or compliance. For instance, LIMS can efficiently process data, generate reports, and offer real-time insights, expediting decision-making and improving the accuracy of lab results. The adoption of these systems ensures that labs maintain high standards while reducing operational inefficiencies.

Additionally, digital transformation allows for the seamless integration of various laboratory functions, creating an interconnected and smooth flow of information. This reduces the occurrence of bottlenecks, eliminates redundant tasks, and optimises resource allocation, resulting in an efficient, error-free operational environment.

Ensuring Data Integrity and Accuracy

Bio Spectrum

Diese Geschichte stammt aus der BioSpectrum India Nov 2024-Ausgabe von Bio Spectrum.

Abonnieren Sie Magzter GOLD, um auf Tausende kuratierter Premium-Geschichten und über 9.000 Zeitschriften und Zeitungen zuzugreifen.

Sie sind bereits Abonnent?

WEITERE GESCHICHTEN VON Bio Spectrum

Bio Spectrum

Bio Spectrum

WHO certifies Suriname malaria-free

Suriname became the first country in the Amazon region to receive malaria-free certification from the World Health Organization (WHO).

time to read

1 min

August 2025

Bio Spectrum

Bio Spectrum

Torrent Pharma buys controlling stake in JB Pharma from KKR for Rs 25,689 Cr valuation

Ahmedabad-based Torrent Pharmaceuticals and global investment firm KKR have announced that Torrent has entered into definitive agreements to acquire controlling stake in Mumbai-based J. B. Chemicals and Pharmaceuticals (JB Pharma) from KKR at an Equity Valuation of Rs 25,689 crore (on fully diluted basis), followed by a merger of the two entities.

time to read

1 min

August 2025

Bio Spectrum

Suraksha Diagnostics injects Rs 22 Cr to establish Eastern India's largest genomics lab

Suraksha Diagnostics, one of the leading diagnostics chains in Eastern India, has launched one of the largest and a state-of-theart genomics lab in Eastern India.

time to read

1 min

August 2025

Bio Spectrum

Illumina buys SomaLogic for $425 M to accelerate proteomics business

Illumina, Inc. has entered into a definitive agreement with Standard BioTools under which Illumina will acquire SomaLogic, a leader in data-driven proteomics technology, and other specified assets for $350 million in cash payable at closing, subject to customary adjustments, plus up to $75 million in near-term performance-based milestones and performance-based royalties.

time to read

1 min

August 2025

Bio Spectrum

Bio Spectrum

Kashmik Formulation to expand capacity, eyes Rs 100 Cr revenue in FY26

Kashmik Formulation, a pharmaceutical manufacturing company headquartered in Ahmedabad, has announced significant expansion plans aimed at increasing production capacity, strengthening its presence in international markets, and enhancing operational efficiencies through automation.

time to read

1 min

August 2025

Bio Spectrum

WHO highlights risks associated with use of semaglutide medicines

The World Health Organisation (WHO) is alerting healthcare professionals and regulatory authorities to the risk of non-arteritic anterior ischemic optic neuropathy (NAION) associated with the use of semaglutide medicinesOzempic, Rybelsus, and Wegovy.

time to read

1 min

August 2025

Bio Spectrum

Bio Spectrum

Lamark Biotech secures Rs 6.5 Cr to accelerate development of thermostable insulin

Lamark Biotech, an innovation-led biopharma startup, has raised Rs 6.5 crore in a PreSeries A round led by IAN Group, including IAN Alpha Fund, powered by BioAngels, Dr Vinayender Tulla, Dr Nita Roy, and Venkataraman KNK, domain experts of IAN's angel investors led the round.

time to read

1 min

August 2025

Bio Spectrum

Bio Spectrum

AstraZeneca invests Rs 166 Cr to expand Global Hub in Bengaluru

AstraZeneca, a global, science-led biopharmaceutical company, has announced the expansion of its state-of-the-art Global Hub in Bengaluru, strengthening its presence in India.

time to read

1 min

August 2025

Bio Spectrum

Bio Spectrum

Novo Nordisk launches injectable Semaglutide for weight management in India

Novo Nordisk, a leading global healthcare company headquartered in Denmark with over a 100-year legacy of chronic disease care, has announced the launch of Wegovy (injectable Semaglutide) in India.

time to read

1 min

August 2025

Bio Spectrum

Bio Spectrum

Can Policy Reforms & Investments Trigger India's MedTech MAKEOVER?

India's MedTech sector has long been import-dependent. The Centre is now working to change this by positioning the country as an export-oriented manufacturing hub. A series of policies and investments have been introduced to support this shift. Have these made an impact? What steps are necessary to strengthen India's position in the global medical technology (MedTech) landscape? Let's find out.

time to read

12 mins

August 2025

Listen

Translate

Share

-
+

Change font size